{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T21:27:43Z","timestamp":1744234063499},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.bbrc.2013.07.131","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T16:01:13Z","timestamp":1375977673000},"page":"635-639","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Runx2 induces bone osteolysis by transcriptional suppression of TSSC1"],"prefix":"10.1016","volume":"438","author":[{"given":"Da-Chuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Nong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.07.131_b0005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jcb.20557","article-title":"A role for Runx2 in normal mammary gland and breast cancer bone metastasis","volume":"96","author":"Shore","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2013.07.131_b0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bone.2010.05.035","article-title":"Metastatic bone disease: role of transcription factors and future targets","volume":"48","author":"Pratap","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bbrc.2013.07.131_b0015","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/MCB.25.19.8581-8591.2005","article-title":"The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion","volume":"25","author":"Pratap","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2013.07.131_b0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1083\/jcb.200409187","article-title":"Terminal osteoblast differentiation, mediated by Runx2 and p27KIP1, is disrupted in osteosarcoma","volume":"167","author":"Thomas","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrc.2013.07.131_b0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11033-008-9378-1","article-title":"Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma","volume":"36","author":"Nathan","year":"2009","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2013.07.131_b0030","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.joca.2004.08.008","article-title":"Regulation of MMP-13 expression by Runx2 and FGF2 in osteoarthritic cartilage","volume":"12","author":"Wang","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bbrc.2013.07.131_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1476-4598-9-171","article-title":"The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells","volume":"9","author":"Mendoza-Villanueva","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2013.07.131_b0040","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1158\/0008-5472.CAN-08-1078","article-title":"Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells","volume":"68","author":"Pratap","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2013.07.131_b0045","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/S1462399408000616","article-title":"Molecular mechanisms and treatment of bone metastasis","volume":"10","author":"Clines","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbrc.2013.07.131_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/138945008784911831","article-title":"Wnt signaling and prostate cancer","volume":"9","author":"Robinson","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbrc.2013.07.131_b0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2006.12.040","article-title":"When prostate cancer meets bone: control by Wnts","volume":"253","author":"Emami","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2013.07.131_b0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10555-006-9022-2","article-title":"The role of Wnts in bone metastases","volume":"25","author":"Hall","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbrc.2013.07.131_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcp.22011","article-title":"Src signaling in cancer invasion","volume":"223","author":"Guarino","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2013.07.131_b0070","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1158\/0008-5472.CAN-10-2603","article-title":"FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2013.07.131_b0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10555-006-9032-0","article-title":"Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone","volume":"25","author":"Pratap","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbrc.2013.07.131_b0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2407-9-102","article-title":"Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis","volume":"9","author":"Cai","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2013.07.131_b0085","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1038\/sj.onc.1207676","article-title":"Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression","volume":"23","author":"Stein","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2013.07.131_b0090","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcb.20958","article-title":"Regulation of osteoblast differentiation by transcription factors","volume":"99","author":"Komori","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2013.07.131_b0095","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1476-4598-9-258","article-title":"Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis","volume":"9","author":"Baniwal","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2013.07.131_b0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/onc.2009.389","article-title":"Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions","volume":"29","author":"Akech","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2013.07.131_b0105","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/bcr2762","article-title":"Cancer-related ectopic expression of the bone-related transcription factor Runx2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility","volume":"12","author":"Leong","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2013.07.131_b0110","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/bcr3073","article-title":"Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2","volume":"13","author":"Chimge","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2013.07.131_b0115","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1101\/gad.1854909","article-title":"Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases","volume":"23","author":"Guise","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2013.07.131_b0120","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1158\/0008-5472.CAN-09-1471","article-title":"Ectopic Runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression","volume":"69","author":"Pratap","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2013.07.131_b0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/bcr3129","article-title":"PTHrP and breast cancer: more than hypercalcemia and bone metastases","volume":"14","author":"Boras-Granic","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2013.07.131_b0130","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/onci.21990","article-title":"Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction","volume":"1","author":"Danilin","year":"2012","journal-title":"Oncoimmunology"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13013168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13013168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T07:48:22Z","timestamp":1715845702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13013168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0006291X13013168"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.07.131","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Runx2 induces bone osteolysis by transcriptional suppression of TSSC1","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.07.131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}